Jeremy Segal to Antineoplastic Agents, Immunological
This is a "connection" page, showing publications Jeremy Segal has written about Antineoplastic Agents, Immunological.
Connection Strength
0.145
-
Secondary resistance to immunotherapy associated with ß-catenin pathway activation or PTEN loss in metastatic melanoma. J Immunother Cancer. 2019 11 08; 7(1):295.
Score: 0.145